Youri Hoogstrate

13PUBLICATIONS
96CO-AUTHORS
Speciation and extinctionMolecular targetsPredictive and prognostic markersSurveying (incl. hydrographic surveying)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 14, 2026
Divergent genomic evolution in astrocytomas and oligodendrogliomas.

|Mar 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.

Rosa Luning, Sybren L N Maas, Pim J French

|Aug 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.

Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen

|Feb 17, 2025
Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligands.

Santoesha A Ghisai, Nastaran Barin, Levi van Hijfte

|Jan 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma.

Levi van Hijfte, Marjolein Geurts, Iris de Heer

|Nov 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

Karin A van Garderen, Wies R Vallentgoed, Anna Lavrova

Pageof 3

Frequent Collaborators

8 joint publications

Pim J French

4 joint publications

Michael Weller

4 joint publications

Pieter Wesseling

4 joint publications

Bart Westerman